PharmDash is a real-world evidence platform that delivers insights into the use, value, and outcomes of different medications across all disease areas. Initially designed to work with the Australian Pharmaceutical Benefits Scheme (PBS) longitudinal patient data, it now has the functionality to ingest and analyze many other patient data sets, covering other health systems and geographies.
PharmDash analyses longitudinal health data to create customized reports. Insights into how patients are treated in any therapy area. PharmDash has a long history of working with diseases like prostate, lung, breast, and blood cancers. The longitudinal focus is effective in chronic diseases such as diabetes, respiratory and cardiovascular disease. Each report has complex algorithms that allow the user to gain insights at the click of a button.
Competitive insights and scenario planning
Pre-launch market sizing, assessment & planning
Performance tracking and reporting
Disease franchise performance
Identify diagnosis and treatment bottlenecks
Optimize patient medicine use
Assess health outcomes
Inform marketing message and content
Create and track patient segments
Understand trends to adapt your tactical approach
Inform resource planning
Understand and influence networks